Loading...
Market
Will AMD invest in another healthcare AI company by end of 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
AMD's official press releases or financial disclosures
Story
AMD Invests $20M in AI-Driven Absci Structured as PIPE to Boost Drug Discovery Efforts
Jan 8, 2025, 11:50 AM
Advanced Micro Devices (AMD) has made a $20 million investment in Absci Corporation (ABSI), a company focused on AI-driven drug discovery. This strategic investment, reported by the Wall Street Journal, is part of AMD's initiative to market its AI semiconductors to the healthcare sector. The investment is structured as a private investment in public equity (PIPE) and aims to assist Absci in reducing its hardware costs by migrating some of its workloads to AMD's technology. This move underscores AMD's commitment to expanding its presence in the healthcare industry through innovative AI applications.
View original story
Similar markets
No • 50%
Yes • 50%
Less than 10% • 25%
20% to 30% • 25%
More than 30% • 25%
10% to 20% • 25%
Kleiner Perkins • 25%
Other existing investor • 25%
A new investor • 25%
General Catalyst • 25%
